Research statistics

Kisspeptin-10 research: publications and trials

What has been published on Kisspeptin-10: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Kisspeptin-10 works or is safe. For what it is and what the studies found, see the Kisspeptin-10 profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

373

Since 1994

Publications in 2026 so far

22

Through November 15, 2026

Human clinical research

9.4%

35 of 373 classified

Registered clinical trials

17

ClinicalTrials.gov

Randomized controlled trials

4

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

87.7%

238 animal · 88 in vitro · 1 computational

Records that only mention it

85

Not counted above

Status in the library: Research only.

What to keep in mind

  • More than 70% of the indexed publications are animal, cell or computational studies.
  • Some completed trials have neither posted results nor a linked results publication.
  • The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.

Publications by year

Kisspeptin-10 publications by year and evidence

1994, Preclinical (animal, in vitro, computational): 1 of 12001, Preclinical (animal, in vitro, computational): 1 of 12004, Preclinical (animal, in vitro, computational): 3 of 32005, Preclinical (animal, in vitro, computational): 8 of 82006, Preclinical (animal, in vitro, computational): 8 of 92006, Reviews and meta-analyses: 1 of 92007, Preclinical (animal, in vitro, computational): 8 of 92007, Reviews and meta-analyses: 1 of 92008, Human clinical research: 1 of 122008, Preclinical (animal, in vitro, computational): 10 of 122008, Reviews and meta-analyses: 1 of 122009, Preclinical (animal, in vitro, computational): 20 of 202010, Human clinical research: 1 of 212010, Preclinical (animal, in vitro, computational): 20 of 212011, Human clinical research: 3 of 162011, Preclinical (animal, in vitro, computational): 13 of 162012, Human clinical research: 2 of 162012, Preclinical (animal, in vitro, computational): 14 of 162013, Human clinical research: 1 of 162013, Preclinical (animal, in vitro, computational): 13 of 162013, Reviews and meta-analyses: 2 of 162014, Human clinical research: 2 of 182014, Preclinical (animal, in vitro, computational): 16 of 182015, Human clinical research: 1 of 122015, Preclinical (animal, in vitro, computational): 11 of 122016, Human clinical research: 2 of 172016, Preclinical (animal, in vitro, computational): 15 of 172017, Human clinical research: 5 of 282017, Preclinical (animal, in vitro, computational): 22 of 282017, Reviews and meta-analyses: 1 of 282018, Human clinical research: 2 of 212018, Preclinical (animal, in vitro, computational): 19 of 212019, Human clinical research: 2 of 122019, Preclinical (animal, in vitro, computational): 9 of 122019, Reviews and meta-analyses: 1 of 122020, Human clinical research: 2 of 152020, Preclinical (animal, in vitro, computational): 12 of 152020, Reviews and meta-analyses: 1 of 152021, Human clinical research: 1 of 152021, Preclinical (animal, in vitro, computational): 13 of 152021, Reviews and meta-analyses: 1 of 152022, Human clinical research: 2 of 212022, Preclinical (animal, in vitro, computational): 19 of 212023, Human clinical research: 1 of 152023, Preclinical (animal, in vitro, computational): 14 of 152024, Human clinical research: 1 of 152024, Preclinical (animal, in vitro, computational): 14 of 152025, Human clinical research: 3 of 302025, Preclinical (animal, in vitro, computational): 26 of 302025, Reviews and meta-analyses: 1 of 302026 (to date), Human clinical research: 3 of 222026 (to date), Preclinical (animal, in vitro, computational): 18 of 222026 (to date), Reviews and meta-analyses: 1 of 22Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analyses0102030199420072012201720222026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesTotal
19940101
20010101
20040303
20050808
20060819
20070819
2008110112
2009020020
2010120021
2011313016
2012214016
2013113216
2014216018
2015111012
2016215017
2017522128
2018219021
201929112
2020212115
2021113115
2022219021
2023114015
2024114015
2025326130
2026 (to date)318122

Study types

Animal study238
In vitro study88
Other clinical trial22
Review11
Observational human study8
Randomized controlled trial4
Case report1
Computational study1

Research areas

From MeSH major topics. A paper can be in several areas.

Reproductive and sexual health179
Endocrinology156
Neurological and mental health86
Oncology50
Metabolic health24
Cardiovascular23
Dermatology14
Immune system13
Antimicrobial and infectious disease11
Gastrointestinal8
Obesity and weight management7
Longevity and aging6

Registered clinical trials

2 of 11 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 11 · Recruiting: 3 · Withdrawn: 2 · Terminated: 1
Phase 1: 10 · Phase 2: 4 · Phase 3: 3

TrialStatusPhaseStartedResults
Kisspeptin to Quantify GnRH Neuronal Function in Health and DiseaseNCT07224490 · 40 enrolledRecruitingPhase 12026-03—
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic AmenorrheaNCT07224438 · 20 enrolledRecruitingPhase 22025-12—
Recall by Genotype: Neuropeptide StimulationNCT05901467 · 16 enrolledTerminatedPhase 12023-10Posted
Dampening the Reproductive Axis With Continuous KisspeptinNCT05971849 · 8 enrolledCompletedPhase 12023-10—
Kisspeptin Administration Subcutaneously to Patients With IHHNCT05896293 · 36 enrolledRecruitingPhase 22023-02—
Kisspeptin Administration Subcutaneously to Patients With Reproductive DisordersNCT05633966 · 13 enrolledCompletedPhase 12022-12—
Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic ClampNCT05456854WithdrawnPhase 12022-06—
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal ToleranceNCT04532801WithdrawnPhase 12019-09—
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic HypogonadismNCT04648969 · 18 enrolledCompletedPhase 22019-05Posted
Administration of Kisspeptin in Patients With HyperprolactinemiaNCT02956447 · 36 enrolledCompletedPhase 22017-11Posted
Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in MenNCT03315325 · 15 enrolledCompletedPhase 32014-08—
Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.NCT03286517 · 30 enrolledCompletedPhase 32014-06—
Neuropeptides in Human ReproductionNCT01952782 · 61 enrolledCompletedPhase 12014-04—
KP-10 and Insulin Secretion in MenNCT03771326 · 14 enrolledCompletedPhase 32013-10—
Kisspeptin in the Evaluation of Delayed PubertyNCT01438034 · 24 enrolledCompletedPhase 12013-06—
Elucidating Kisspeptin Physiology by Blocking Kisspeptin SignalingNCT01438073 · 96 enrolledCompletedPhase 12011-09—
Kisspeptin Administration in the AdultNCT00914823 · 256 enrolledCompletedPhase 12009-06—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men.

    European journal of endocrinology · August 1, 2026 · Randomized controlled trial · cited 0 times · open access

    PMID 42549827 · DOI 10.1093/ejendo/lvag134 · Human clinical research

  2. Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome.

    Human reproduction (Oxford, England) · June 1, 2020 · Randomized controlled trial · cited 58 times · open access

    PMID 32510130 · DOI 10.1093/humrep/deaa104 · Human clinical research

  3. Interactions Between Neurokinin B and Kisspeptin in Mediating Estrogen Feedback in Healthy Women.

    The Journal of clinical endocrinology and metabolism · September 16, 2016 · Randomized controlled trial · cited 50 times · open access

    PMID 27636018 · DOI 10.1210/jc.2016-2132 · Human clinical research

  4. An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo.

    Endocrinology · May 1, 2008 · Randomized controlled trial · cited 273 times · open access

    PMID 18450954 · DOI 10.1210/en.2008-0231 · Human clinical research

  5. Dynamic modulation of LH secretion by continuous kisspeptin infusion in healthy men.

    Hormones (Athens, Greece) · June 2, 2026 · Other clinical trial · cited 0 times · open access

    PMID 42230485 · DOI 10.1007/s42000-026-00795-y · Human clinical research

  6. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans.

    Journal of neuroendocrinology · November 22, 2025 · Other clinical trial · cited 1 times · open access

    PMID 41273106 · DOI 10.1111/jne.70114 · Human clinical research

  7. Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans.

    European journal of endocrinology · March 1, 2025 · Other clinical trial · cited 9 times · open access

    PMID 39965102 · DOI 10.1093/ejendo/lvaf001 · Human clinical research

  8. Mechanism of LH release after peripheral administration of kisspeptin in cattle.

    PloS one · December 2, 2022 · Other clinical trial · cited 9 times · open access

    PMID 36459509 · DOI 10.1371/journal.pone.0278564 · Human clinical research

  9. Kisspeptin Overcomes GnRH Neuronal Suppression Secondary to Hyperprolactinemia in Humans.

    The Journal of clinical endocrinology and metabolism · July 1, 2022 · Other clinical trial · cited 39 times · open access

    PMID 35323937 · DOI 10.1210/clinem/dgac166 · Human clinical research

  10. Kisspeptin induces ovulation in heifers under low plasma progesterone concentrations.

    Theriogenology · September 4, 2019 · Other clinical trial · cited 19 times

    PMID 31494459 · DOI 10.1016/j.theriogenology.2019.08.033 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse.

    Endocrinology · June 24, 2004 · Animal study · cited 1,160 times

    PMID 15217982 · DOI 10.1210/en.2004-0431 · Animal studies

  2. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty.

    The Journal of neuroscience : the official journal of the Society for Neuroscience · December 1, 2005 · Animal study · cited 1,035 times · open access

    PMID 16339030 · DOI 10.1523/jneurosci.3328-05.2005 · Animal studies

  3. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates.

    Proceedings of the National Academy of Sciences of the United States of America · January 31, 2005 · Animal study · cited 877 times · open access

    PMID 15684075 · DOI 10.1073/pnas.0409822102 · Animal studies

  4. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition.

    Endocrinology · June 2, 2005 · Animal study · cited 557 times

    PMID 15932928 · DOI 10.1210/en.2005-0337 · Animal studies

  5. Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha.

    Neuroscience letters · April 18, 2006 · Animal study · cited 509 times

    PMID 16621281 · DOI 10.1016/j.neulet.2006.03.039 · Animal studies

Latest publications

  1. Regulation of PACAP gene expression by ovarian sex steroids and kisspeptin: Study using hypothalamic cell lines and an <i>in vivo</i> female rat model.

    Biochemistry and biophysics reports · October 17, 2026 · In vitro study · cited 0 times

    PMID 42936012 · DOI 10.1016/j.bbrep.2026.102834 · In vitro studies

  2. Kisspeptin-10 alleviates OGD/R-induced H9c2 cardiomyocyte injury by triggering autophagy via regulating the YY1/TFEB axis.

    Cytotechnology · October 12, 2026 · In vitro study · cited 0 times · open access

    PMID 42871171 · DOI 10.1007/s10616-026-01089-2 · In vitro studies

  3. Kisspeptin-10 Alleviates Obesity-induced Testicular Oxidative Stress and Mitochondrial Dysfunction via Modulation of Mitophagy and Autophagy Signaling.

    Reproductive sciences (Thousand Oaks, Calif.) · September 28, 2026 · Animal study · cited 0 times

    PMID 42806235 · DOI 10.1007/s43032-026-02211-7 · Animal studies

  4. Enzymatic Stability and Comparative Effects of Kisspeptin-14, Kisspeptin-13 and Kisspeptin-10 on Beta-Cell Function, Glucose Homeostasis and Appetite Regulation.

    Metabolites · September 17, 2026 · Animal study · cited 0 times · open access

    PMID 42783811 · DOI 10.3390/metabo16090686 · Animal studies

  5. Maternal Kisspeptin-10 Treatment Partially Rescues Fetal and Postnatal Cardiac Programming Disrupted by Maternal Hypothyroidism.

    Cardiovascular toxicology · September 11, 2026 · Animal study · cited 0 times · open access

    PMID 42726152 · DOI 10.1007/s12012-026-10185-w · Animal studies

  6. Structural basis for Kisspeptin-10 selectivity toward KISS1R: computational insights.

    In silico pharmacology · September 6, 2026 · Computational study · cited 0 times · open access

    PMID 42707558 · DOI 10.1007/s40203-026-00726-0 · Computational studies

  7. Kisspeptin System: A Modulator of Neuroinflammation and Behaviour in Temporal Lobe Epileptic Rats.

    Molecular neurobiology · September 1, 2026 · Animal study · cited 0 times

    PMID 42680947 · DOI 10.1007/s12035-026-06171-6 · Animal studies

  8. Effects of intraperitoneal administration of kisspeptin-10 on ischemia-reperfusion injury in a rat testicular torsion and detorsion model.

    Veterinary research forum : an international quarterly journal · August 15, 2026 · Animal study · cited 0 times

    PMID 42979496 · DOI 10.30466/vrf.2025.2068679.4873 · Animal studies

  9. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men.

    European journal of endocrinology · August 1, 2026 · Randomized controlled trial · cited 0 times · open access

    PMID 42549827 · DOI 10.1093/ejendo/lvag134 · Human clinical research

  10. Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.

    The Analyst · July 27, 2026 · In vitro study · cited 0 times

    PMID 42328738 · DOI 10.1039/d6an00455e · In vitro studies

Browse all 373 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Kisspeptin-10; Kisspeptin-112-121; Kp-10; Metastin 45-54

((TITLE_ABS:"Kisspeptin-10" OR CHEM:"Kisspeptin-10" OR TITLE_ABS:"Kisspeptin10" OR CHEM:"Kisspeptin10") OR (TITLE_ABS:"Kisspeptin-112-121" OR CHEM:"Kisspeptin-112-121" OR TITLE_ABS:"Kisspeptin112-121" OR CHEM:"Kisspeptin112-121") OR (TITLE_ABS:"Kp-10" OR CHEM:"Kp-10" OR TITLE_ABS:"Kp10" OR CHEM:"Kp10") OR (TITLE_ABS:"Metastin 45-54" OR CHEM:"Metastin 45-54" OR TITLE_ABS:"Metastin45-54" OR CHEM:"Metastin45-54")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Kisspeptin-10 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/kisspeptin-10